Episode 24: Overview of the Latest Guidance in IgA Nephropathy Management

episode

KDIGO Conversations in Nephrology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Chris Hipkins: Labour Leader on their policy costings in the wake of PREFU, Adrian Rurawhe's death 10 min · 29 Sep 2026 · The Mike Hosking Breakfast

Nobody Knows What A Coincidence Is 36 min · 29 Sep 2026 · Toni and Ryan

NEW Nancy Guthrie Note?! Teresa Giudice Breaks Her Silence on Milania + Lindsay Clancy INNOCENT?! 52 min · 29 Sep 2026 · No Filter With Zack Peter

NPR News: 09-29-2026 2PM EDT 5 min · 29 Sep 2026 · NPR News Now

2PM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Deebo & Joe - Part 1: Reaction to Bears Beating Eagles + Maurkice Pouncey Joins 1h 4m · 29 Sep 2026 · Club Shay Shay

Report any issue

Source

Recorded02 Oct 2025

Publisheranchor.fm ↗

Handlerec:11055787

Show notes

Join Dana Rizk, MD (University of Alabama at Birmingham, United States), and Brad Rovin, MD (Ohio State University, United States), Co-Chair of the 2025 KDIGO IgAN/IgAV Guideline, for a deep dive into the latest updates in patient care. Their conversation explores the most important takeaways from the new guideline, the critical role of kidney biopsies in diagnosis and prognosis, the use of the IgAN prediction tool for risk assessment, and the updated thresholds and treatment goals designed to improve outcomes.This podcast was supported by Travere.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in